We recently finemapped a type 1 diabetes (T1D)-linked region on chromosome 21, indicating that one or more T1D-linked genes exist in this region with 33 annotated genes. In the current study, we have taken a novel approach using transcriptional profiling in predicting and prioritizing the most likely candidate genes influencing beta-cell function in this region. Two arraybased approaches were used, a rat insulinoma cell line (INS-1ab) overexpressing pancreatic duodenum homeobox 1 (pdx-1) and treated with interleukin 1b (IL-1b) as well as human pancreatic islets stimulated with a mixture of cytokines. Several candidate genes with likely functional significance in T1D were identified. Genes showing differential expression in the two approaches were highly similar, supporting the role of these specific gene products in cytokine-induced beta-cell damage. These were genes involved in cytokine signaling, oxidative phosphorylation, defense responses and apoptosis. The analyses, furthermore, revealed several transcription factor binding sites shared by the differentially expressed genes and by genes demonstrating highly similar expression profiles with these genes. Comparable findings in the rat beta-cell line and human islets support the validity of the methods used and support this as a valuable approach for gene mapping and identification of genes with potential functional significance in T1D, within a region of linkage.
Introduction
Identification of susceptibility genes in complex genetic diseases is a major challenge. In the process of identifying disease-associated genes, classically two strategies have been used, the functional candidate gene approach and the positional approach. The functional candidate gene approach takes advantage of existing knowledge about the disease and genes are selected based on this knowledge. This approach has been extensively used, although, with varying success in type 1 diabetes (T1D). With the positional approach, linkage analysis is used to determine location of disease-linked regions. The gene(s), thus identified, are subsequently further examined and their functional significance is evaluated. Linkage peaks typically cover megabase (Mb)-wide regions, but workload, data management and costs for finemapping can be significantly reduced by prioritizing genes for further analysis. In the present study, we have used transcriptional profiling in selecting the most likely candidate genes based on functional significance. T1D (MIM 222100) is a complex genetic disease of unknown etiology. In a previous T1D genome scan, 1 a region on chromosome 21 showed some evidence of linkage to T1D, especially in the Danish population (LOD 2.33, P ¼ 0.009). We have recently finemapped this region, also in the Danish population, to a 6.3 Mb interval with a peak NPL score of 3.61 (P ¼ 0.0002). 2 Thirty-three known genes were identified in this region (www.ncbi.nlm.nih. gov), and all known single-nucleotide polymorphisms (SNPs) in coding regions of these genes (dbSNP, http:// www.ncbi.nlm.nih.gov/SNP/index.html, build 116) were examined. Globally, none of the SNPs showed association to T1D. 2 However, subsets of data (e.g. families responsible for the linkage signal) demonstrated T1D association of four genes: TTC3, OLIG2, KCNE1 and CBR1. From a statistical point, all 33 genes, positioned underneath the linkage peak, are equally good candidate genes. Consequently, they should all be extensively studied. Expression levels of the genes, may, however, act as intermediate phenotypes between genomic DNA sequence variations and more complex disease pheno-types; 3 and variation in gene expression has been shown in large part as an outcome of polymorphisms in DNA sequence. 3, 4 We have, therefore, taken a novel approach for gene mapping, which uses transcriptional profiling as a method to select candidate genes within a region, that is, prioritizing the genes of interest for further investigation. In the present study, we have used model systems primarily addressing beta-cell function and response.
Gene expression was evaluated by means of two arraybased approaches. The first approach was based on a rat insulinoma cell line (INS-1ab) overexpressing pancreatic duodenum homeobox 1 (pdx-1). 5, 6 Beta-cell maturation is dependent on sequential activation of different transcription factors, including pdx-1, 5 and is accompanied by increased sensitivity to the toxic effects of interleukin 1b (IL-1b). 7 Cytokines have been shown to play a key role in the destruction of beta cells, 8 and we have demonstrated an increased sensitivity to IL-1b in INS-1ab overexpressing pdx-1. 6 Extensive microarray analysis was carried out with these cells treated with IL-1b for different periods of time. In the second approach, human pancreatic islets from eight donors were examined in another array-based evaluation of gene expression of the 33 positional human candidate genes with and without stimulation with a mixture of cytokines, mimicking the presumed pathogenesis of T1D in humans.
Results
Gene expression was evaluated by means of two different array-based approaches focusing on beta-cell function. Expression was evaluated in a rat beta-cell line overexpressing pdx-1, exposed to IL-1 for 2 and 24 h. Of the 33 human genes, 27 have homologues in the rat. Twenty of these were represented by one or more probe sets on the Affymetrix rat chip used, and were subjected to analysis in this rat beta-cell system. Of these, the CBR3 (carbonyl reductase 3), DSCR1 (Down's syndrome critical region protein 1, Calcipressin-1) and CRYZL1 (quinine oxidoreductase-like 1) genes were downregulated when comparing pdx-1-overexpressing cells stimulated with IL-1b vs unstimulated pdx-1-overexpressing cells ( Figure 1 and Table 1 ). In contrast, the ATP5O (ATPsynthase O subunit) and IFNGR2 (interferon-gamma receptor beta chain precursor) genes were upregulated in the presence of IL-1b ( Figure 1 and Table 1 ). Additionally, the IFNAR1 (interferon-alpha/beta receptor alphachain precursor) (P ¼ 0.01), DSCR5 (phosphatidylinositol N-acetylglucosaminyltransferase subunit P, PIGP) (P ¼ 0.03), TIAM1 (T-lymphoma invasion and metastasis-inducing protein 1) (P ¼ 0.01) and OLIG1 (oligodendrocyte transcription-factor 1) (P ¼ 0.001) genes were all upregulated by pdx-1 overexpression at 2 h and/or 24 h, as compared with the control situation without pdx-1 overexpression, independently of IL-1b stimulation. The CHAF1B (chromatin assembly factor 1 subunit-B) gene was downregulated (P ¼ 0.003) by pdx-1 overexpression, Table 1 .
Second, human pancreatic islet preparations from eight donors were examined in a separate array-based evaluation of gene expression of all 33 positional human candidate genes with and without stimulation with a mixture of cytokines. Several of the chromosome 21 candidate genes demonstrated expression levels that were downregulated in human islets following cytokine exposure, that is, ITSN1 (intersectin-1), TTC3 (tetratricopeptide repeat protein-3), CHAF1B, HUNK (hormonally upregulated neu tumor-associated kinase), OLIG1 and CBR1 (carbonyl reductase 1) ( Figure 2 and Table 1 ). Of these, HUNK and ITSN1 did not have a homologous gene in the rat and TTC3 was not on the rat Affymetrix chip. Genes demonstrated to be differentially expressed in both approaches were CHAF1B, OLIG1 and CBR1/ CBR3.
Common expression patterns of genes may reflect shared regulatory mechanisms. Promoter regions of the selected genes were, therefore, compared for common Figure 1 Expression levels in rat genes (corresponding to human chromosome 21 genes), which are differentially expressed after IL-1b stimulation. Expression levels are expressed relative to unstimulated condition, and are provided for 2 and 24 h of IL-1b stimulation. *Comparisons with P-values o0.05. The CBR3 (P ¼ 0.04), DSCR1 (P ¼ 0.001) and CRYZL1 (P ¼ 0.03) genes were downregulated after IL-1b stimulation, whereas the IFNGR2 (P ¼ 1.4 Â 10
À7
) and ATP5O (P ¼ 0.006) genes were upregulated in the presence of IL-1b. Findings observed in this model system of course need confirmation in additional functional studies using other systems.
Transcriptional profiling of T1D genes on Chr. 21 R Bergholdt et al transcription factor binding sites. We initially compared genes having a human chromosome 21 annotation (Ensembl), which demonstrated a differential level of expression in either the pdx-1 system or the human islets. Several transcription factor binding sites shared by several of the genes were identified (Supplementary Table 1 ), but no statistically significant overrepresentation of any transcription factor binding site in these promoters was detected, although data clearly suggested shared regulatory mechanisms. Additionally, analyses were carried out separately in the group of genes downregulated by IL-1b/cytokine mix, the group upregulated by IL-1b, as well as the group upregulated by pdx-1 overexpression. In none of the groups, we were able to demonstrate significantly overrepresented transcription factor binding sites.
For the pdx-1-overexpressing INS-1ab cell system, the expression levels of more than 30 000 rat genes were measured on the rat chip. We used several approaches to extract additional information from this system. The corresponding proteins, for the 10 differentially expressed chromosome 21 homologous genes in the pdx1-system (Table 1) , were used as input proteins for searches in a protein interaction database (potential interactions of proteins, www.bmm.icnet.uk/~pip). 9 For each of the interacting proteins, the corresponding rat gene, if present, was identified on the chip. Genes, whose corresponding protein could be predicted to interact with the input chromosome 21 gene and, which in addition demonstrated expression profiles similar to the original gene (correlation coefficient40.7) were selected (Table 2) . Furthermore, genes, which could not be shown to interact at the protein level with the input gene, but which showed a highly similar expression profile (correlation coefficient40.95) to one or more of the 10 input genes were identified as well (Supplementary  Table 2 ). In total, 68 additional rat genes (with LocusLink IDs) were hereby identified. Each of these groups of genes was tested for overrepresented Gene Ontology (GO) terms. One term, biological process: 'GO:0006952 Defense response', was significantly overrepresented among the group of genes highly similar in expression to IFNGR2 (Supplementary Table 2 ) (corrected Pvalueo0.032). Specifically, four genes were annotated 
Thirty-three human chromosome 21 genes are listed, with indication of whether a corresponding rat gene exists, and whether represented by a probe set on the Affymetrix rat chip used. Genes showing differential expression in either system (human islets or rat insulinoma cells) are indicated. Genes represented on the Affymetrix rat chip is listed in physical map order.
Transcriptional profiling of T1D genes on Chr. 21 R Bergholdt et al with this GO term: IL15, FAS, ICAM1 as well as SOD2 (rat gene Sodm), which have all previously been associated with T1D. [10] [11] [12] [13] [14] [15] [16] FAS, ICAM1 and SOD2 shared transcription factor binding sites in their promoter regions for NFKAPPAB65 and NFKAPPAB_01, which are also found in other genes in this group of genes with similar expression, that is, IFNGR2 and MAPK6. Other genes in the group of genes with expression patterns highly similar to IFNGR2, have common binding sites for NFkbib.
Discussion
Identification of susceptibility genes in complex genetic diseases is a major challenge. High heritability of variation in gene expression has been demonstrated 3 and suggests that identification of genetic determinants of gene expression may provide insights into the molecular basis of complex traits, like T1D. As our recent fine-mapping data strongly suggest the existence of T1D-linked gene(s) in a region on human chromosome 21, further characterization of the candidate genes herein is important. Transcriptional profiling is a novel and innovative approach, which has proven its feasibility. By selecting genes that change expression levels after cytokine exposure in human islets and in a rat beta-cell line, we believe it is possible to select genes with a likely functional significance in T1D pathogenesis. Functional human candidate genes are genes that exhibit changes in expression level during cytokine exposure, modeling the pathogenetic process in the target organ of T1D, that is, up-or down-regulation, as well as changes from not being expressed to being expressed after cytokine exposure.
In the current study, we have used models, which preferentially focus on beta-cell function and response. Despite the fact that T1D is an immune-mediated disease Figure 2 Expression levels of differentially expressed genes in human pancreatic islets. Grey bars represent unstimulated conditions (expression level defined as 1). Black bars represent cytokine-stimulated conditions related to expression levels in unstimulated condition of the same islet preparation (numbered 1-8 on the x-axis). The y-axis shows fold up-or downregulation. Significant upregulation after cytokine exposure, as expected, for several control genes, for example, NOS2A (Figure 2 ), IL6 and CASP1 (data not shown) was demonstrated. The following chromosome 21 candidate gene transcripts demonstrated expression levels that were all downregulated in human islets following cytokine exposure: ITSN1 (P ¼ 0.003), TTC3 (P ¼ 0.02), CHAF1B (P ¼ 0.02), HUNK (P ¼ 0.02), OLIG1 (P ¼ 0.05) and CBR1 (P ¼ 0.22). Of these, HUNK and ITSN1 did not have a homologous gene in the rat and TTC3 are not found on the rat Affymetrix chip. and the few validated T1D genes to date are immune system genes, we believe the immune system destroys beta cells because of features in beta cells themselves, for example, the way they react to the immunological challenge. 17 To explore this further, we therefore focused on beta-cell genes and used the cytokine stimulation model, mimicking what is happening in the target tissue in T1D pathogenesis. We can, of course, not rule out that important disease genes are expressed only in immunological tissue.
Although it is not always straightforward to extrapolate from one species to the other, high concordance was observed between expression changes in the rat beta-cell line and human pancreatic islets. Genes demonstrated to be differentially expressed in both approaches were CHAF1B, OLIG1 and CBR1/CBR3. Additionally, TTC3 was downregulated in human pancreatic islets and demonstrated T1D association in our genetic studies. 2 The molecular function of the protein encoded by the TTC3 gene is, however, largely unknown. The CBR1 gene was also associated to T1D in families demonstrating linkage in our previous genetic studies, 2 substantiating the relevance of this gene in T1D. CBR1/CBR3 are two very similar neighboring genes, believed to be able to substitute each other in at least some biological processes. We have previously, in proteome analyses of IL-1b-exposed islets from diabetes-prone rats, demonstrated Cbr-1 protein to be downregulated fivefold by IL-1b exposure. 18 The CBR1, CBR3 and ATP5O genes are furthermore involved in oxidative phosphorylation with potential implication for oxidative stress, believed to be of importance in beta-cell destruction. Of additional interest are the IFNGR2 and IFNAR1 genes involved in interferon signaling and map kinase signaling cascades. Cytokine and cytokine receptor genes are obvious T1D functional candidate genes because of the presumed key role of cytokines in the pathogenesis of the disease. A main finding in the rat beta-cell line was the IFNGR2 gene, which was significantly upregulated by IL-1b. The IFNGR2 gene was, however, not differentially expressed in the human pancreatic islets, which might represent differences in signaling between human and rat. 19 Furthermore, interferon-g (IFN-g) was used for stimulation of the human islets as opposed to the rat beta-cell line studies, where only IL-1b was used. The two Down's syndrome critical region proteins (DSCR1 and DSCR5), differentially expressed in the IL-1b stimulated pdx-1 cells, may also be of potential interest. We have recently demonstrated the prevalence of Down's syndrome in T1D to be four times increased, supporting genes on chromosome 21 to be responsible for this higher prevalence. 20 Such genes might also be important in T1D in general.
The analyses revealed several transcription factor binding sites shared by several of the promoters of the differentially expressed genes; none, however, demonstrated statistically significant overrepresentation. This suggests common regulation and functional interaction of the chromosome 21 region with regions on other chromosomes (e.g. via transcription factors), rather than among the chromosome 21 genes themselves.
In conclusion, we demonstrated several candidate genes with a likely functional significance in T1D. Several of the genes, identified by these approaches, were genes involved in T1D relevant pathways as signal transduction, oxidative phosphorylation, defense responses and apoptosis. Data prove the feasibility and usefulness of using expression profiling in relevant tissues for gene mapping, and in selecting functional candidate genes presumed to underlie complex genetic diseases.
Materials and methods

Pdx-1-overexpressing INS-1 cells
Cell culture: The tetracycline-inducible, stably transfected INS-1ab cell line has been described previously. 5 Cells were cultured in RPMI 1640 with or without 500 ng/ml doxycycline. After 24 h, IL-1b (40 ng/ml) 6 was added, and cells were harvested at 2, 4, 6, 12 and 24 h, respectively. Insulin and nitric oxide measurements were carried out on media to confirm an effect of the IL-1b exposure. 6 RNA and array processing were carried out as described in. Interacting proteins with similar expression profile (correlation coefficient40.7) are shown. The Pearson correlation coefficient, which captures similarity in shape, was calculated (based on all time points and treatments) between each of the input genes and all genes whose protein interacts with the corresponding protein for that input gene. The threshold of 40.7 was chosen after visual comparison of expression profiles. 'Distance' refers to 1-correlation coefficient.
Transcriptional profiling of T1D genes on Chr. 21
Gene expression in INS-1 cells Affymetrix RG 230 (Affymetrix Inc., Santa Clara, CA, USA) 2.0 oligonucleotide arrays were scanned (Affymetrix GeneChip Scanner) and probe intensities were normalized and log 2 -transformed. 21 Significant differential expression was assessed by using multivariate analysis considering all arrays simultaneously to judge statistical significance. 22 Briefly, for each gene, empirical Bayes-moderated F-statistics were used to test for differences between samples. Genes were considered to be significantly differentially regulated, if P-values adjusted for multiple testing using the false discovery rate (FDR) 23 were o0.05. Microarray studies do test many hypotheses; however, use of other methods than conservative mass significance-controlling methods are generally accepted. 24, 23 A gene-specific FDR is interpreted as the Bayesian probability that a gene, declared to be differentially expressed, is a false positive. 24, 23 The Pearson correlation coefficient (which captures similarity in shape), based on all time points and treatments, was used to evaluate similarity in expression profiles among genes. Overrepresented GO terms (www.geneontology. org) among groups of genes were detected by calculating P-values using the hypergeometric distribution and adjusting for multiple testing, using the Bonferroni correction. When overrepresented GO terms were found in this manner, the corresponding biological processes were assumed to be of special importance among the group of genes tested.
Human pancreatic islets
Human pancreatic islets were obtained as samples from a multicenter European Union-supported program on beta-cell transplantation in diabetes directed by Professor D Pipeleers. The program has been approved by central and local ethical committees. Eight human pancreatic islet preparations were used, five from male donors and three from female donors, aged 8-57 years. The islets were stimulated with a mixture of cytokines, consisting of TNF-a (5000 U/ml), IFN-g (750 U/ml) and IL-1b (75 U/ml). cDNA was prepared from total RNA by oligo-dT-primed reverse transcription, as described by the manufacturer (TaqMan RT reagents, Applied Biosystems, Foster City, CA, USA).
Gene expression in human islets
Gene expression quantification in eight human islet preparations was evaluated by Low Density Array Cards (Applied Biosystems), containing assays for all 33 genes as well as several control genes. These are custom arrays, very sensitive (less than 1% divergence among duplicates) and based on real-time PCR and TaqMan (7900HT, Applied Biosystems) technology. Low Density Array Cards were processed according to instructions by the manufacturer. Data were analyzed using the SDS 2.1 software (Applied Biosystems) and evaluated by the 2 ÀDDCt method, 25 normalizing all gene expressions to the expression of the housekeeping gene GAPDH, and subsequently comparing each islet preparation for each gene in cytokine-stimulated condition vs unstimulated condition. Expression levels were compared using a paired t-test, P-values of o0.05 were considered statistically significant for differential expression.
Searching for common transcription factor binding sites Searches for transcription factor binding sites were carried out using an algorithm based on a frequency residue model as implemented in Toucan version 2.3.2 (www.homes.esat.kuleuven.be/~saerts/software/toucan. php) 26 with links to relevant databases, containing human and rat background models and frequency files, respectively. Testing for statistically overrepresented transcription factor binding sites were carried out using a binomial test (Po0.05 and significance value 40), also implemented in the Toucan software.
